Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.
The diagnosis, treatment, and monitoring of the primary systemic vasculitides associated with circulating antineutrophil cytoplasm autoantibodies (ANCA) have formed the focus of a multicenter collaborative study. Consensus has been reached on criteria for classification, clinical subgroupings by ext...
Үндсэн зохиолчид: | Jayne, DR, Rasmussen, N |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
1997
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
-н: Mukhtyar, C, зэрэг
Хэвлэсэн: (2006) -
Comments on: Antineutrophil cytoplasmic autoantibody associated vasculitis-Clinical profile and outcomes
-н: Rohini Handa
Хэвлэсэн: (2018-01-01) -
Ischaemic stroke as the first presentation of antineutrophilic cytoplasmic autoantibody‐associated vasculitis
-н: John Chuan Nguyen Tran, зэрэг
Хэвлэсэн: (2022-12-01) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
-н: Flossmann, O, зэрэг
Хэвлэсэн: (2006) -
Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis with Kidney Involvement in a Patient with AL Amyloidosis
-н: Brendan L. Thoms, зэрэг
Хэвлэсэн: (2021-07-01)